News

Primary outcome data from a phase III clinical trial evaluating aflibercept (Eylea, Regeneron) for macular edema (ME) due to branch retinal vein occlusion (BRVO) show that intravitreal treatment with the anti-VEGF agent was well tolerated and associated with significantly better improvements in visual acuity and central retinal thickness (CRT) than laser photocoagulation.

Novaliq GmbH has announced the commencement of a phase I study for its dry eye syndrome treatment, cyclosporine solution (CyclASol), following United States and European patent approval.

BioLight Israeli Life Sciences Investments’ subsidiary, ViSci, has filed an investigational new drug (IND) application with the FDA to conduct a phase I/IIa clinical study with its treatment for glaucoma-a subconjunctival Latanoprost controlled-release insert.

Congress has approved legislation delaying for 1 year a massive 24% Medicare fee cut, which had been scheduled to take effect April 1, as well as implementation of the ICD-10-CM coding system.

Shunt implantation and trabeculectomy are important procedures in the battle to prevent blindness from glaucoma, and tubes are steadily gaining in popularity possibly because of the more predictable postoperative course.

Ophthalmologists may be first to make a diagnosis of eye cancer in patients who present with ocular tumors and should be aware of the various forms and types of disease.

A diffractive trifocal IOL (FineVision, PhysIOL) provides a peak modulation transfer function for intermediate vision.

A dual-optic accommodating IOL (Synchrony, Abbott Medical Optics) seems to have met the presbyopic challenge by providing good vision at far and intermediate distances.

A new optical coherence tomography (OCT)-based method for IOL power selection has been found to be a promising method for achieving good refractive outcomes when performing cataract surgery in eyes with a history of laser vision correction, according to analyses of data from a retrospective comparative case series.

The FDA has granted 510(k) clearance to Bausch + Lomb’s comprehensive surgical platform-the Stellaris PC Vision Enhancement System-for the integrated 523-nm laser and software.

Alimera Sciences has resubmitted its New Drug Application (NDA) for its fluocinolone acetonide intravitreal implant (Iluvien) to the FDA.

Ophthalmic Women Leaders (OWL) has announced it will honor three award winners during its signature “OWL Monday” reception and program held in conjunction with the American Society of Cataract and Refractive Surgery meeting in Boston.

Findings from recent clinical trials are providing some guidance on oxygen management in preterm infants.

An ophthalmologist compares two currently available fluidics systems and their ability to recover after occlusion is interrupted.

Regional rather than global analysis of visual fields may produce more precise assessments of glaucomatous progression following trabeculectomy, since the surgery seems to have differential effects.

This month’s simultaneous meeting of the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators will convene in Boston from April 25 to 29.

An array of IOLs under development and in clinical trials show promise for correcting presbyopia or addressing other limitations of existing pseudophakic lenses.

Computer-assisted techniques help achieve the best possible results in complicated cases of anatomic reconstruction.

A newly introduced reusable injector system simplifies delivery and placement of a glistening-free, hydrophobic acrylic IOL in the experience of one ophthalmologist.

New tools for pediatric glaucoma surgery are becoming available that improve the ability to examine pediatric patients, perform surgeries more easily, and enhance treatment of difficult cases.

Photocoagulation with a navigated laser is safe and significantly reduces the need for further anti-vascular endothelial growth factor injections in patients with diabetic macular edema.

In vivo confocal microscopy has enormous potential to be used in a large number of physiological and pathological ocular conditions.

Some people say that laughter is the best medicine, whereas others may argue in favor of antibiotics, erectile dysfunction therapies, and medicinal cannabis. Settling arguments about the comparative value of these therapeutic agents is, however, a topic for another day. This editorial seeks to shed light upon the laughter that involves, or is directed at, us physicians.

A custom flexible, silicone iris prosthesis (CustomFlex, HumanOptics) provides visual and cosmetic improvements for patients with complete or partial aniridia.

A new guidance device is one of the first instruments of its kind to provide surgeons with objective data pre- and postoperatively for placement of a small-aperture corneal inlay (Kamra, AcuFocus).

In difficult neuro-ophthalmology cases, selecting the correct imaging tools and trusting the skill of the radiologist are highly important.

Why maintaining a good communication relationship with your staff is important for internal relationships and balance of power.

An upgraded three-dimensional viewing and recording system for ophthalmic surgery is a useful tool for the surgeon and surgical team members in the operating room.

The American Academy of Ophthalmology (AAO) has officially launched the Intelligent Research in Sight (IRIS) Registry, the United States’ first comprehensive eye disease and condition registry.

Projections on ophthalmology workforce size in the future-as well as growth in patient demand for services-indicates a clear need for more efficient delivery of glaucoma care. Going on the assumption that a tele-ophthalmological approach offers a possible solution, researchers at Johns Hopkins University, Baltimore, undertook a survey to gauge patient acceptance.